ISREC – Swiss Institute for Experimental Cancer Research

Douglas Hanahan elected Foreign Member of the Royal Society

Published:10.05.23 — EPFL Professor Douglas Hanahan has been elected among eighty researchers as a Foreign Member of the Royal Society in the UK.

How genome doubling helps cancer develop

Published:28.03.23 — Researchers at EPFL and UNIL have uncovered a new way in which cancer can develop: whole genome doubling (WGD) changes the way DNA is organized in the 3D space, leading to the activation of oncogenes that drive cancer growth.

Drug combo breaks down cancer resistance to immunotherapy

Published:13.01.23 — By combining a checkpoint inhibitor with a new immunocytokine, scientists at EPFL, Ludwig Institute for Cancer Research, CHUV and Roche have made a breakthrough in fighting against immunotherapy-resistant cancers.